TrialThe American journal of pathology2010

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.

Sara Rodriguez-Acebes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.